Back to AMGNView full pipeline
Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
1
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
Competitive Landscape
18 competitors in Rheumatoid Arthritis
View Full LandscapeDrug Information
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Regulatory Approvals
EMA2/13/2017
Lifmior
Rheumatoid arthritis; Juvenile idiopathic arthritis Psoriatic arthritis; Axial spondyloarthritis; Plaque psoriasis; Paediatric plaque psoriasis.
View on EMADrug Science
Mechanism of action & safety profile
Related Pipeline
MetoprololPhase 3
Cardiovascular Disease
TarlatamabPhase 3
Small Cell Lung Cancer
romosozumab HCP administration with PFSPhase 3
Post-Menopausal Osteoporosis
Omitted Vincristine+Dexamethasone pulsesPhase 3
Leukemia, Acute Lymphoblastic
Inotuzumab Ozogamicin+Standard Maintenance TherapyPhase 3
Leukemia, Acute Lymphoblastic
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
